Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 4
2006 1
2007 2
2008 8
2009 9
2010 5
2011 5
2012 7
2013 3
2014 13
2015 17
2016 13
2017 11
2018 11
2019 7
2020 5
2021 11
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, Tettero JM, Bachas C, Baer C, Béné MC, Bücklein V, Czyz A, Denys B, Dillon R, Feuring-Buske M, Guzman ML, Haferlach T, Han L, Herzig JK, Jorgensen JL, Kern W, Konopleva MY, Lacombe F, Libura M, Majchrzak A, Maurillo L, Ofran Y, Philippe J, Plesa A, Preudhomme C, Ravandi F, Roumier C, Subklewe M, Thol F, van de Loosdrecht AA, van der Reijden BA, Venditti A, Wierzbowska A, Valk PJM, Wood BL, Walter RB, Thiede C, Döhner K, Roboz GJ, Cloos J. Heuser M, et al. Among authors: jorgensen jl. Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626. Blood. 2021. PMID: 34724563 Free PMC article.
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Schuurhuis GJ, Heuser M, Freeman S, Béné MC, Buccisano F, Cloos J, Grimwade D, Haferlach T, Hills RK, Hourigan CS, Jorgensen JL, Kern W, Lacombe F, Maurillo L, Preudhomme C, van der Reijden BA, Thiede C, Venditti A, Vyas P, Wood BL, Walter RB, Döhner K, Roboz GJ, Ossenkoppele GJ. Schuurhuis GJ, et al. Among authors: jorgensen jl. Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12. Blood. 2018. PMID: 29330221 Free PMC article. Review.
Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
Fang H, Wang SA, Hu S, Konoplev SN, Mo H, Liu W, Zuo Z, Xu J, Jorgensen JL, Yin CC, El Hussein S, Jelloul FZ, Tang Z, Medeiros LJ, Wang W. Fang H, et al. Among authors: jorgensen jl. Cytometry B Clin Cytom. 2022 Jul;102(4):283-291. doi: 10.1002/cyto.b.22085. Epub 2022 Jun 18. Cytometry B Clin Cytom. 2022. PMID: 35716019 Free article.
Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.
Thomas DA, O'Brien S, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Ravandi F, Verstovsek S, Jorgensen JL, Bueso-Ramos C, Andreeff M, Pierce S, Garris R, Keating MJ, Cortes J, Kantarjian HM. Thomas DA, et al. Among authors: jorgensen jl. J Clin Oncol. 2010 Aug 20;28(24):3880-9. doi: 10.1200/JCO.2009.26.9456. Epub 2010 Jul 26. J Clin Oncol. 2010. PMID: 20660823 Free PMC article. Clinical Trial.
B-acute lymphoblastic leukemia/lymphoblastic lymphoma.
Loghavi S, Kutok JL, Jorgensen JL. Loghavi S, et al. Among authors: jorgensen jl. Am J Clin Pathol. 2015 Sep;144(3):393-410. doi: 10.1309/AJCPAN7BH5DNYWZB. Am J Clin Pathol. 2015. PMID: 26276770 Review.
Association between SV40 and non-Hodgkin's lymphoma.
Butel JS, Vilchez RA, Jorgensen JL, Kozinetz CA. Butel JS, et al. Among authors: jorgensen jl. Leuk Lymphoma. 2003;44 Suppl 3:S33-9. doi: 10.1080/10428190310001623784. Leuk Lymphoma. 2003. PMID: 15202523 Review.
125 results